Signaling · Cell-signaling research peptide · LYMK-002
IFN-gamma Antagonist
- Drug class
- Cell-signaling research peptide
- Status
- Research use only
- Catalog code
- LYMK-002
- Also known as
- LYMK-002
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What IFN-gamma Antagonist is studied for
- Protein–protein interaction (PPI) mapping
- SH2, SH3, PDZ, and 14-3-3 binding studies
- Allosteric modulator and PPI-inhibitor discovery
- Signal-pathway dissection in cellular models
Mechanism of action
IFN-gamma Antagonist sits within the Signaling research class (CPC reference LYMK-002). Signaling peptides mimic recognition motifs (phosphotyrosine motifs, PDZ ligands, kinase docking sites) or interfere with protein–protein interactions inside the cell, allowing focused perturbation of a single node in a pathway. Investigators typically incorporate IFN-gamma Antagonist as a reference standard, tool ligand, or substrate in the assay contexts listed above. SPR, BLI, AlphaScreen, and pulldown / Western readouts.
Frequently asked questions
What is IFN-gamma Antagonist?
IFN-gamma Antagonist (CPC catalog code LYMK-002) is a synthetic cell-signaling research peptide in the signaling category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
What is IFN-gamma Antagonist studied for?
Published and internal research programs use IFN-gamma Antagonist as a reference standard in signaling workflows — for example, protein–protein interaction (ppi) mapping and sh2, sh3, pdz, and 14-3-3 binding studies. Human clinical evidence is not established.
Is IFN-gamma Antagonist FDA-approved for human use?
No. IFN-gamma Antagonist is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
How is IFN-gamma Antagonist typically used in the lab?
In a signaling workflow, IFN-gamma Antagonist is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. SPR, BLI, AlphaScreen, and pulldown / Western readouts.
How should IFN-gamma Antagonist be stored?
Store lyophilized at −20 °C. Aliquot in DMSO or aqueous buffer per solubility. Follow your institution's standard operating procedures for handling synthetic peptides.
Where does the IFN-gamma Antagonist product page point to?
This kindr reference page mirrors CPC Scientific's catalog metadata for LYMK-002. The upstream reference sheet — including sequence, purity, MW, and application notes where published — is linked from the buy panel. All orders placed on kindr Peptides ship internationally under research-use terms only.
What quality specifications apply to IFN-gamma Antagonist?
Research-grade peptides in the CPC catalog are synthesized by solid-phase peptide synthesis (SPPS), purified by preparative RP-HPLC, and characterized by analytical HPLC and mass spectrometry. Typical purity is ≥95%; certificate of analysis is available on request.
Related peptides in Signaling
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal